ERDF-Seed Fund Ltd is subsidiary of Finnvera Plc. Finnvera is a specialized financing company owned by the State of Finland.
Tarrex Biopharma is a privately held startup drug discovery company, located in Xiamen, China. Tarrex focuses on developing innovative therapeutics for the treatment of cancer. Tarrex’s lead asset, TX803, is novel small molecule drug candidate with a unique molecular mechanism for the treatment of colorectal cancer.